Literature DB >> 11179339

Interleukin-12- and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice.

R A Gramzinski1, D L Doolan, M Sedegah, H L Davis, A M Krieg, S L Hoffman.   

Abstract

Unmethylated CpG dinucleotides in bacterial DNA or synthetic oligodeoxynucleotides (ODNs) cause B-cell proliferation and immunoglobulin secretion, monocyte cytokine secretion, and activation of natural killer (NK) cell lytic activity and gamma interferon (IFN-gamma) secretion in vivo and in vitro. The potent Th1-like immune activation by CpG ODNs suggests a possible utility for enhancing innate immunity against infectious pathogens. We therefore investigated whether the innate immune response could protect against malaria. Treatment of mice with CpG ODN 1826 (TCCATGACGTTCCTGACGTT, with the CpG dinucleotides underlined) or 1585 (ggGGTCAACGTTGAgggggG, with g representing diester linkages and phosphorothioate linkages being to the right of lowercase letters) in the absence of antigen 1 to 2 days prior to challenge with Plasmodium yoelii sporozoites conferred sterile protection against infection. A higher level of protection was consistently induced by CpG ODN 1826 compared with CpG ODN 1585. The protective effects of both CpG ODNs were dependent on interleukin-12, as well as IFN-gamma. Moreover, CD8+ T cells (but not CD4+ T cells), NK cells, and nitric oxide were implicated in the CpG ODN 1585-induced protection. These data establish that the protective mechanism induced by administration of CpG ODN 1585 in the absence of parasite antigen is similar in nature to the mechanism induced by immunization with radiation-attenuated P. yoelii sporozoites or with plasmid DNA encoding preerythrocytic-stage P. yoelii antigens. We were unable to confirm whether CD8+ T cells, NK cells, or nitric oxide were required for the CpG ODN 1826-induced protection, but this may reflect differences in the potency of the ODNs rather than a real difference in the mechanism of action of the two ODNs. This is the first report that stimulation of the innate immune system by CpG immunostimulatory motifs can confer sterile protection against malaria.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11179339      PMCID: PMC98068          DOI: 10.1128/IAI.69.3.1643-1649.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

Authors:  M Roman; E Martin-Orozco; J S Goodman; M D Nguyen; Y Sato; A Ronaghy; R S Kornbluth; D D Richman; D A Carson; E Raz
Journal:  Nat Med       Date:  1997-08       Impact factor: 53.440

2.  CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants.

Authors:  G B Lipford; M Bauer; C Blank; R Reiter; H Wagner; K Heeg
Journal:  Eur J Immunol       Date:  1997-09       Impact factor: 5.532

Review 3.  Functional diversity of helper T lymphocytes.

Authors:  A K Abbas; K M Murphy; A Sher
Journal:  Nature       Date:  1996-10-31       Impact factor: 49.962

4.  Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway.

Authors:  A K Yi; D M Klinman; T L Martin; S Matson; A M Krieg
Journal:  J Immunol       Date:  1996-12-15       Impact factor: 5.422

5.  Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization.

Authors:  G J Weiner; H M Liu; J E Wooldridge; C E Dahle; A M Krieg
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

6.  Sterile protection of monkeys against malaria after administration of interleukin-12.

Authors:  S L Hoffman; J M Crutcher; S K Puri; A A Ansari; F Villinger; E D Franke; P P Singh; F Finkelman; M K Gately; G P Dutta; M Sedegah
Journal:  Nat Med       Date:  1997-01       Impact factor: 53.440

7.  Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA.

Authors:  Z K Ballas; W L Rasmussen; A M Krieg
Journal:  J Immunol       Date:  1996-09-01       Impact factor: 5.422

8.  Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity.

Authors:  D L Doolan; M Sedegah; R C Hedstrom; P Hobart; Y Charoenvit; S L Hoffman
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

9.  Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides.

Authors:  J S Cowdery; J H Chace; A K Yi; A M Krieg
Journal:  J Immunol       Date:  1996-06-15       Impact factor: 5.422

10.  CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity.

Authors:  R S Chu; O S Targoni; A M Krieg; P V Lehmann; C V Harding
Journal:  J Exp Med       Date:  1997-11-17       Impact factor: 14.307

View more
  43 in total

1.  The use of CpG as an adjuvant to Toxoplasma gondii vaccination.

Authors:  Jennifer A Spencer; Bruce F Smith; Anthony J Guarino; Byron L Blagburn; Henry J Baker
Journal:  Parasitol Res       Date:  2004-01-15       Impact factor: 2.289

2.  Immunostimulatory and anti-neoplasm effects of a novel palindrome CpG oligodeoxynucleotide in mice.

Authors:  Hai-yan Du; Li-hou Dong; Bi-jun Zhao; Jie Fu; Qing-qing Wang; Fang Chen; Lun Ou; Na Li; Xiao Sun; Zhong-ming Tang; Hai-feng Song
Journal:  Acta Pharmacol Sin       Date:  2012-06-25       Impact factor: 6.150

3.  Contribution of nitric oxide to CpG-mediated protection against Listeria monocytogenes.

Authors:  Shuichi Ito; Ken J Ishii; Atsushi Ihata; Dennis M Klinman
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

4.  CD40 is required for protective immunity against liver stage Plasmodium infection.

Authors:  Sara A Murray; Isaac Mohar; Jessica L Miller; Katherine J Brempelis; Ashley M Vaughan; Stefan H I Kappe; Ian N Crispe
Journal:  J Immunol       Date:  2015-02-02       Impact factor: 5.422

5.  Innate immune responses induced by CpG oligodeoxyribonucleotide stimulation of ovine blood mononuclear cells.

Authors:  Angelo Mena; Anil K Nichani; Yurij Popowych; Dale L Godson; Donna Dent; Hugh G G Townsend; George K Mutwiri; Rolf Hecker; Lorne A Babiuk; Philip Griebel
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

6.  CpG oligodeoxynucleotides inhibit tumor growth and reverse the immunosuppression caused by the therapy with 5-fluorouracil in murine hepatoma.

Authors:  Xian-Song Wang; Zhen Sheng; You-Bing Ruan; Yang Guang; Mu-Lan Yang
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

7.  Tweaking Innate Immunity: the Promise of Innate Immunologicals As Anti-infectives.

Authors:  Kenneth L Rosenthal
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-09       Impact factor: 2.471

8.  Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.

Authors:  D Lys Guilbride; Pawel Gawlinski; Patrick D L Guilbride
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

9.  Comparison of Plasmodium berghei challenge models for the evaluation of pre-erythrocytic malaria vaccines and their effect on perceived vaccine efficacy.

Authors:  Wolfgang W Leitner; Elke S Bergmann-Leitner; Evelina Angov
Journal:  Malar J       Date:  2010-05-27       Impact factor: 2.979

10.  Recombinant viral vaccines expressing merozoite surface protein-1 induce antibody- and T cell-mediated multistage protection against malaria.

Authors:  Simon J Draper; Anna L Goodman; Sumi Biswas; Emily K Forbes; Anne C Moore; Sarah C Gilbert; Adrian V S Hill
Journal:  Cell Host Microbe       Date:  2009-01-22       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.